Short answer: no, you cannot develop sickle cell disease later in life. It is not contagious, it is not caused by diet, stress, infection, or exposure to chemicals, and no adult has ever “caught” it. Sickle cell disease is determined at the moment of conception, when you inherit one abnormal beta-globin gene from each parent. If you didn’t inherit two copies, you will never have the disease — no matter what happens to you afterward.
What can happen — and what fuels this question in my clinic — is that someone is diagnosed for the first time as a teenager or adult. That’s a diagnosis of a condition that was always there, not a new disease. It happens with milder genotypes like HbSC or HbS/β⁺-thalassemia, and in people born before universal newborn screening or in countries where screening isn’t routine.
Why Sickle Cell Disease Can’t Be Acquired
Sickle cell disease is caused by a single point mutation in the HBB gene on chromosome 11: glutamic acid is swapped for valine at position 6 of the beta-globin chain. That swap produces hemoglobin S, which polymerizes when deoxygenated and warps the red cell into a rigid crescent.
The mutation lives in your DNA from your very first cell. Your bone marrow can only build hemoglobin from the genetic instructions it was given. There is no mechanism by which normal adult marrow spontaneously starts producing HbS across every red cell line.
Compare that with acquired anemias — iron deficiency, B12 deficiency, autoimmune hemolysis, chemotherapy-induced marrow suppression. Those genuinely develop. Sickle cell disease does not. The full story of how this mutation spread through human populations is covered in the origins and implications of sickle cell disease.
The Inheritance Math
Both parents must pass along a sickle gene. When two carriers have a child, the odds are fixed for every pregnancy — they don’t “use up” after one affected child.
| Parent 1 | Parent 2 | Child outcome | Probability |
|---|---|---|---|
| Carrier (AS) | Carrier (AS) | Sickle cell disease (SS) | 25% |
| Carrier (AS) | Carrier (AS) | Sickle cell trait (AS) | 50% |
| Carrier (AS) | Carrier (AS) | Unaffected (AA) | 25% |
| Disease (SS) | Unaffected (AA) | All children carriers (AS) | 100% |
| Disease (SS) | Carrier (AS) | Disease (SS) | 50% |
| Carrier (AS) | Carrier (AC or Aβ-thal) | HbSC or HbS/β-thal disease | 25% |
Roughly 1 in 13 Black or African American babies in the United States is born with sickle cell trait, and about 1 in 365 with sickle cell disease. The gene is also common in people of Mediterranean, Middle Eastern, South Asian, Caribbean, and Central/South American ancestry — because carrying one copy offered partial protection against falciparum malaria.
Can Sickle Cell Trait Turn Into Disease?
No. This is the second most common version of the question, and the answer is equally firm. Sickle cell trait (HbAS) is not a mild form of the disease and it does not convert. You have one normal gene, and it does the heavy lifting for life.
People with trait have normal hemoglobin levels, a normal red cell lifespan, and normal life expectancy. Under extreme conditions — severe dehydration, high-altitude flight in unpressurized aircraft, exhaustive exercise without fluids — a small number experience complications such as exertional rhabdomyolysis or splenic infarction. Those are rare stress events, not a transformation into disease.
Why Some People Are Diagnosed as Adults
Late diagnosis is real. Here’s why it happens:
- Milder genotypes. HbSC disease and HbS/β⁺-thalassemia often produce baseline hemoglobin near 10–12 g/dL with few childhood crises. The first clue may be retinopathy, avascular necrosis of the hip, or an unexplained painful episode in the twenties or thirties.
- Born before screening. Universal US newborn screening only became nationwide in 2006. Many adults were never tested.
- Immigration from countries without screening programs.
- Hereditary persistence of fetal hemoglobin. High HbF levels blunt sickling and delay symptom onset for years.
- Records lost. A positive newborn screen was never communicated to the family.
Symptoms That Should Prompt Testing
Because HbS polymerization damages the red cell membrane, affected cells survive roughly 10–20 days instead of the usual 120-day lifespan of normal red blood cells. That chronic hemolysis plus vaso-occlusion drives the symptom picture:
- Chronic anemia with fatigue and pallor (baseline Hb often 6–9 g/dL in HbSS)
- Episodic severe bone pain — the vaso-occlusive crisis
- Dactylitis (painful swelling of hands and feet) in infants and toddlers
- Jaundice and scleral icterus from elevated indirect bilirubin
- Recurrent infections, especially encapsulated organisms, after functional asplenia
- Delayed growth and puberty in children
- Priapism, leg ulcers, vision changes, stroke symptoms
How It’s Diagnosed
| Test | What it shows |
|---|---|
| Hemoglobin electrophoresis / HPLC | Gold standard — quantifies HbS, HbA, HbA2, HbF, HbC |
| Newborn screening (heel stick) | Reported as FS (disease), FAS (trait), FSC, FSA |
| Complete blood count | Anemia, elevated reticulocytes, high MCV on hydroxyurea |
| Peripheral blood smear | Sickled cells, target cells, Howell-Jolly bodies |
| Sickle solubility (“Sickledex”) | Screening only — cannot distinguish trait from disease |
| DNA sequencing of HBB | Confirms genotype, used in prenatal and preimplantation testing |
Ask specifically for hemoglobin electrophoresis. A solubility test alone is not enough — it turns positive in both trait and disease.
Treatment: What Actually Changes Outcomes
- Hydroxyurea — raises fetal hemoglobin and cuts crisis frequency; the backbone of care since 1998
- Penicillin prophylaxis from 2 months to age 5, plus pneumococcal and meningococcal vaccination
- Transcranial Doppler screening annually from ages 2–16 to identify stroke risk
- Chronic transfusion for stroke prevention, with iron chelation
- L-glutamine, crizanlizumab, voxelotor — newer agents for crisis reduction and hemolysis
- Allogeneic stem cell transplant — curative, best results with matched sibling donors
- Gene therapy (exagamglogene autotemcel, lovotibeglogene autotemcel) — FDA-approved in 2023
Median survival has climbed substantially with comprehensive care; see our breakdown of the life span of sickle cell patients for genotype-specific numbers.
When to See a Doctor
Go to the emergency department for fever above 101°F (38.5°C), chest pain or shortness of breath, sudden weakness or trouble speaking, priapism lasting over 2 hours, or pain not controlled at home.
Book a non-urgent appointment if you have unexplained chronic anemia, a family history of sickle cell in any ancestry group, or you’re planning a pregnancy and don’t know your carrier status.
FAQ
Can you get sickle cell disease from a blood transfusion?
No. Transfused cells are temporary and donor blood carrying HbS is screened out for certain recipients. Your own marrow keeps producing your own hemoglobin.
Can sickle cell disease skip a generation?
The disease appears to skip generations because carriers are symptom-free. The gene passes silently until two carriers have a child together.
Can you have sickle cell disease and not know it?
Yes, with milder genotypes like HbSC. Some people reach their thirties before an eye exam, hip MRI, or first crisis reveals it.
Can two parents with trait have all healthy children?
Absolutely. Each pregnancy independently carries a 25% chance of disease — a family can have four unaffected children or two affected ones.
Does sickle cell disease get worse with age?
Crisis frequency often peaks in the late teens and twenties, while cumulative organ damage — kidney, lung, heart — accrues over decades.
Key Takeaways
- Sickle cell disease is inherited at conception and cannot be developed, caught, or acquired.
- Sickle cell trait never converts into disease.
- Adult diagnosis means a missed diagnosis, not a new disease.
- Hemoglobin electrophoresis is the test to request.
- Carrier testing before pregnancy gives couples real, actionable information.
For broader context on blood disorders and how they’re evaluated, explore our guide to hematology and blood health. This article is educational and not a substitute for personal medical advice.
